GRAIL, Inc. (GRAL) – What Are Analysts Saying About This Stock?

GRAIL, Inc. (NASDAQ:GRAL) has earned a consensus rating of “Hold” from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $119.80.

Several equities analysts have recently weighed in on the company. Morgan Stanley increased their price target on GRAIL from $60.00 to $120.00 and gave the company an “equal weight” rating in a report on Monday, October 12th. Wall Street Zen upgraded GRAIL from a “sell” rating to a “hold” rating in a research note on Sunday, September 13th. Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a research note on Thursday, October 15th. TD Cowen upped their price target on shares of GRAIL from $88.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. Finally, Guggenheim increased their price objective on shares of GRAIL from $75.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st.

GRAIL Price Performance

Shares of GRAIL stock opened at $133.76 on Tuesday. GRAIL has a 1 year low of $41.50 and a 1 year high of $166.48. The firm has a market cap of $5.97 billion, a price-to-earnings ratio of -13.72 and a beta of 2.83. The company has a 50-day moving average of $113.10 and a 200 day moving average of $78.71.

GRAIL (NASDAQ:GRAL) last issued its earnings results on Wednesday, August 5th. The company reported ($2.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.66) by $0.10. GRAIL had a negative net margin of 236.95% and a negative return on equity of 15.88%. The business had revenue of $44.69 million during the quarter, compared to analysts’ expectations of $42.39 million. On average, equities analysts anticipate that GRAIL will post -10.07 EPS for the current year.

Insider Activity at GRAIL

In other GRAIL news, insider Andrew Partridge sold 7,873 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $146.39, for a total transaction of $1,152,528.47. Following the completion of the sale, the insider directly owned 155,865 shares of the company’s stock, valued at approximately $22,817,077.35. This represents a 4.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Aaron Freidin sold 23,619 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $146.39, for a total transaction of $3,457,585.41. Following the completion of the transaction, the chief financial officer owned 225,364 shares in the company, valued at $32,991,035.96. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 129,944 shares of company stock worth $14,832,805. 1.83% of the stock is owned by company insiders.

Hedge Funds Weigh In On GRAIL

A number of institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE lifted its position in shares of GRAIL by 29.0% in the first quarter. Bank of America Corp DE now owns 914,114 shares of the company’s stock valued at $47,241,000 after acquiring an additional 205,611 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in shares of GRAIL by 255.6% in the second quarter. Russell Investments Group Ltd. now owns 28,403 shares of the company’s stock worth $1,939,000 after acquiring an additional 20,416 shares during the period. State Street Corp boosted its stake in shares of GRAIL by 26.1% in the second quarter. State Street Corp now owns 2,385,514 shares of the company’s stock worth $162,859,000 after acquiring an additional 493,621 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of GRAIL during the second quarter worth about $1,171,000. Finally, BlackRock Inc. grew its position in shares of GRAIL by 20.5% during the second quarter. BlackRock Inc. now owns 3,577,075 shares of the company’s stock worth $244,207,000 after purchasing an additional 608,539 shares in the last quarter.

GRAIL Company Profile

GRAIL, Inc (NASDAQ: GRAL) is a healthcare company focused on developing blood-based screening technologies for the early detection of cancer. Its principal product is Galleri, a multi-cancer early detection test designed to identify DNA patterns associated with multiple types of cancer from a single blood sample.

Galleri is intended for use alongside recommended cancer screenings and is available by prescription through qualified healthcare providers in the United States. The test is offered as a laboratory-developed test and has not been approved or cleared by the U.S.